Market revenue in 2023 | USD 1,257.4 million |
Market revenue in 2030 | USD 1,466.6 million |
Growth rate | 2.2% (CAGR from 2023 to 2030) |
Largest segment | Subunit vaccines |
Fastest growing segment | Subunit Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Subunit Vaccines, Inactivated, Live Attenuated, MRNA vaccines, Viral vector vaccines |
Key market players worldwide | Serum Institute of India Pvt. Ltd., CSL Ltd, Sanofi SA, GSK PLC, Merck & Co Inc, Pfizer Inc, Sinovac Biotech Ltd, BioNTech SE ADR, AstraZeneca PLC, Moderna Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine market will help companies and investors design strategic landscapes.
Subunit vaccines was the largest segment with a revenue share of 34.12% in 2023. Horizon Databook has segmented the South Korea vaccine market based on subunit vaccines, inactivated, live attenuated, mrna vaccines, viral vector vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
The South Korea vaccine market is anticipated to grow owing to increasing healthcare expenditure, favorable government initiatives, and a high burden of flu & other infectious diseases. Moreover, several vaccine manufacturing expansions by market players are another factor fueling the country’s market.
In addition, strategic activities by the government will further offer lucrative opportunities during the study period. For instance, in May 2023, the WHO and the Republic of Korea formalized a Memorandum of Understanding to establish a global training hub specializing in biomanufacturing.
This training center is intended to cater to Low- and Middle-income Countries (LMICs), enabling them to produce vital biological products, including vaccines, insulin, monoclonal antibodies, and cancer medicines.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea vaccine market , including forecasts for subscribers. This country databook contains high-level insights into South Korea vaccine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account